Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiac resynchronization therapy-always with ICD?].

Christoph Stellbrink1

  • 1Klinik für Kardiologie und internistische Intensivmedizin, Städtische Kliniken, Bielefeld. CHRISTOPH.STELLBRINK@SK-BIELEFELD.DE

Herz
|December 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An externally validated machine learning algorithm for predicting mental and physical health outcomes three months post-hospitalization for severe viral infection with SARS-CoV-2.

Brain, behavior, & immunity - health·2026
Same author

Cardiac Biomarkers to Refine Pretest Probability for Coronary Obstruction and Predict Survival After Revascularization in Chronic Coronary Syndrome.

Journal of the American Heart Association·2026
Same author

[The EHRA/HRS/APHRS/LAHRS/AEPC consensus statement on the management of atrial tachycardias : Implications of the SMART-AT 10-point plan for clinical practice and healthcare structures].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

[Same-day discharge in electrophysiology : Overview for the practice].

Herz·2026
Same author

Genetic contribution to severe COVID-19 in adults under 60 years without major comorbidities in the German National Pandemic Cohort Network (NAPKON).

Human genomics·2026
Same author

Prolonged Smartphone-Based Photoplethysmography for Heart Rhythm Monitoring After Repeat Ablation of Atrial Fibrillation - A 6-Month Prospective Study on mHealth Compliance, Motivation and Arrhythmia Recurrence.

Heart, lung & circulation·2026
Same journal

[Heart and climate].

Herz·2026
Same journal

Multidimensional psychosocial screening in routine cardiac care: preliminary findings from a cross-sectional survey.

Herz·2026
Same journal

[Noise and the heart].

Herz·2026
Same journal

[The cardiovascular exposome: areas of action for prevention and practical cardiology].

Herz·2026
Same journal

Relationship between HAVOC score and new-onset atrial fibrillation in patients with ST elevation myocardial infarction.

Herz·2026
Same journal

Interventional treatment of atrioventricular valves.

Herz·2026
See all related articles

Sudden cardiac death is a major concern in heart failure. Implantable cardioverter-defibrillators (ICDs) are effective in preventing sudden cardiac death, especially when combined with cardiac resynchronization therapy.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Context:

  • Sudden cardiac death (SCD) accounts for approximately 50% of mortality in heart failure patients.
  • Implantable cardioverter-defibrillators (ICDs) have demonstrated superiority over antiarrhythmic drugs for SCD prevention in specific patient groups.
  • The efficacy of prophylactic ICDs in unselected heart failure populations is under investigation.

Purpose:

  • To evaluate the role of prophylactic implantable cardioverter-defibrillator (ICD) therapy in reducing mortality in unselected heart failure patients.
  • To assess the added benefit of ICDs in patients undergoing cardiac resynchronization therapy (CRT).
  • To discuss the influence of recent studies on system choice for CRT.

Summary:

  • Studies show that ICDs are superior to antiarrhythmic drugs in preventing sudden cardiac death in heart failure patients with coronary artery disease and reduced left ventricular function.

Related Experiment Videos

  • For heart failure patients with intraventricular conduction delay, who are candidates for CRT, prophylactic ICD implantation offers minimal additional risk and significant survival benefit.
  • Recent research confirms the benefits of both conventional ICD therapy and biventricular pacing in heart failure management.

    • Impact:

    • Prophylactic ICD implantation can significantly reduce mortality in selected heart failure patients.
    • The combination of ICD and CRT may be optimal for patients with heart failure and conduction delays.
    • Findings guide clinical decision-making regarding device selection for heart failure patients at risk of sudden cardiac death.